Usman, Baby Girl .
HRN: 12-21-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/21/2025
12/28/2025
IV
55mg
Q24H
Potentially Septic Newborn
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines